Loss of p16 Protein Expression in Ovarian Tumors
Author Information
Author(s): S Marchini, AM Codegonil, C Bonazzi, S Chiari, M Broggini
Primary Institution: Istituto di Ricerche Farmacologiche 'Mario Negri'
Hypothesis
Does the p16 gene play a role in ovarian cancer through mutations or deletions?
Conclusion
The study found that while p16 gene deletions were absent, a significant percentage of ovarian tumors showed decreased p16 protein expression.
Supporting Evidence
- 42 primary ovarian carcinomas were analyzed for p16 gene mutations.
- No deletions or mutations were found in the p16 gene.
- 26% of the tumors showed no p16 protein expression.
- CDK4 protein was expressed in all tumor specimens.
Takeaway
In some ovarian cancer patients, a protein called p16 is not made, which might be important for understanding how the cancer grows.
Methodology
The study analyzed p16 gene mutations and protein expression using PCR, Southern blot analysis, and Western blot analysis.
Limitations
The study did not explore all potential mechanisms for p16 silencing and was limited by the number of tumor samples.
Participant Demographics
42 ovarian cancer patients, with varying stages and histological types.
Want to read the original?
Access the complete publication on the publisher's website